Oak Ridge National Laboratory

Oak Ridge National Laboratory industry collaboration enables job growth, N95 mask production in Florida

28-Oct-2020 2:15 PM EDT, by Oak Ridge National Laboratory

Newswise — A collaboration between the Department of Energy’s Oak Ridge National Laboratory and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.

DemeTECH, a medical device manufacturer, is the state’s only National Institute for Occupational Safety and Health certified producer of the respirator masks which are needed to protect U.S. healthcare workers in the fight against COVID-19.

“We had no capability to make this material but wanted to be able to ramp up the production quickly,” said Luis Arguello, Jr., vice president of DemeTECH. “Through a connection at the U.S. Department of Defense’s Advanced Functional Fabrics of America, we were introduced to Oak Ridge National Laboratory and their recent success in making filter media material.”

National user facility resources

Scientific research that began at the DOE’s Carbon Fiber Technology Facility at ORNL provided melt blown filter material to DemeTECH so that they could develop their mask manufacturing processes. At the beginning of the COVID-19 pandemic in the U.S., ORNL researchers were presented with the challenge of how to produce filtration material on existing equipment typically used to mass produce precursor material for carbon fiber production.

CFTF Director Merlin Theodore turned to the precursor line’s melt blowing capability for the answer. The N95 mask is made of melt-blown polypropylene, or PP, a non-woven material that is permanently electrostatically charged with millions of microfibers layered on top of each other. The filter is capable of removing more than 95 percent of submicron particles found in viruses like COVID-19.

Melt blowing is the nonwoven process that makes microfibers into a fabric by scattering a polymer resin at a high air velocity. Randomly deposited fibers form a sheet of material applicable for filtration. Theodore and team consulted with Dr. Peter Tsai, the inventor of N95 electrostatically charged filter material, to integrate the process into the melt blowing line at the CFTF.

Tsai worked with the CFTF team to develop an inline charging technology for the melt blowing line and coordinated with staff at the DOE’s Manufacturing Demonstration Facility on material blending. Researchers across multiple disciplines at ORNL in materials science, characterization and systems and electrical engineering collaborated to adjust the speed and feed of the material to achieve the optimum production target.

“We’ve been successful in melt blowing PP continuously on the CFTF equipment,” Theodore said. “We successfully produced electrostatically charged filter media that met N95 target properties within 28 days.”

U.S. production

Before COVID-19, DemeTECH primarily manufactured wound closure medical devices such as surgical sutures and hernia mesh. The company began production of surgical and N95 masks in response to healthcare supply demand.

“We’re glad we connected with Oak Ridge National Lab and the Carbon Fiber Technology Facility at a time when they needed to transfer their research achievements to industry because we’re now able to mass produce and supply this critical material,” Arguello said.

Since pivoting the company’s capabilities to producing masks, DemeTECH has also opened two additional production facilities.

ORNL’s COVID manufacturing efforts are conducted in coordination with the U.S. Department of Health and Human Services and funded in part by the DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19, with funding provided by the Coronavirus CARES Act. DOE’s Carbon Fiber Technology Facility COVID-19 efforts at ORNL are also supported by the Office Energy Efficiency and Renewable Energy’s Advanced Manufacturing Office

ORNL is managed by UT-Battelle for the U.S. Department of Energy's Office of Science, the single largest supporter of basic research in the physical sciences in the United States. DOE’s Office of Science is working to address some of the most pressing challenges of our time. For more information, please visit https://energy.gov/science.


Filters close

Showing results

110 of 4156
Newswise: Stimulus Relief Funds Increase Social Distancing to Stop Spread of COVID-19
23-Nov-2020 5:20 PM EST
Stimulus Relief Funds Increase Social Distancing to Stop Spread of COVID-19
University of California San Diego

As case rates of COVID-19 reach new heights across the nation, many states and cities are tightening stay-at-home restrictions to stop the spread. New research suggests that that those suffering from economic hardships are less likely comply with new stay-at-home orders; however these same U.S. residents would be more likely to adhere to the new public health guidelines if their households received stimulus funds.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Dec-2020 9:15 AM EST Released to reporters: 30-Nov-2020 2:30 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2020 9:15 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded covid-19-update-surge-preparedness-vaccine-distribution
Released: 30-Nov-2020 2:20 PM EST
COVID-19 Update: Surge Preparedness, Vaccine Distribution

With the novel coronavirus spreading across the U.S. at a record pace, Cedars-Sinai has been seeing an increase in COVID-19 patients at its hospitals and through its network of physicians. But the health system's leaders say Cedars-Sinai is prepared.

Released: 30-Nov-2020 1:20 PM EST
Rethink COVID-19 infection control to keep primary schools open this winter, governments urged

An urgent rethink of infection control policies to keep COVID-19 infection at bay in schools is needed if primary schools are to be kept open this winter, and the knock-on effects on their families avoided, argue children's infectious disease specialists in a viewpoint, published online in the Archives of Disease in Childhood.

Newswise: Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Released: 30-Nov-2020 12:45 PM EST
Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Hackensack Meridian Health

Don’t Delay Your Care – Our dnhanced pandemic safety precautions prioritize patient health and allow providers to deliver outstanding in-office, telehealth and surgical care

Released: 30-Nov-2020 12:10 PM EST
Struggles of care home staff during COVID-19 first wave revealed in Whatsapp messages
University of Leeds

Analysis of social media messages between care home staff on the coronavirus front line reveal their growing concerns over how to manage in the face of the virus.

Released: 30-Nov-2020 11:30 AM EST
More than one-third of children with COVID-19 show no symptoms: study
University of Alberta Faculty of Medicine & Dentistry

More than one-third of kids who have COVID-19 are asymptomatic, according to a University of Alberta study that suggests youngsters diagnosed with the disease may represent just a fraction of those infected.

Newswise: Promising lab results in quest to find naturally occurring anti-COVID therapies
24-Nov-2020 5:35 PM EST
Promising lab results in quest to find naturally occurring anti-COVID therapies
University of Alabama Huntsville

So far, 35 of 125 naturally occurring compounds identified computationally at The University of Alabama in Huntsville (UAH) to have potential against COVID-19 have shown efficacy in ongoing first-batch testing at the University of Tennessee Health Science Center’s Regional Biocontainment Laboratory (UTHSC RBL) that’s the next step in the process to becoming a drug.

Released: 30-Nov-2020 9:45 AM EST
Rutgers Leading Coronavirus Therapeutic Clinical Trial
Rutgers University-New Brunswick

Rutgers is leading a clinical trial assessing the efficacy of a three-drug combination in treating people infected with SARS-CoV-2 and asymptomatic or mildly symptomatic.

Showing results

110 of 4156